title: Bilateral Facial Palsy following Ipilimumab Infusion for Melanoma.
authors.affiliation: Department of Otolaryngology-Head and Neck Surgery, University of Cincinnati College of Medicine, and Neurosensory Disorders Center at the University of Cincinnati Neuroscience Institute, Cincinnati, OH, USA.
authors.forename: Ashley L
authors.initials: AL
authors.lastname: Altman
authors.affiliation: Department of Otolaryngology-Head and Neck Surgery, University of Cincinnati College of Medicine, and Neurosensory Disorders Center at the University of Cincinnati Neuroscience Institute, Cincinnati, OH, USA Department of Otolaryngology-Head and Neck Surgery, Columbia University, New York, New York, USA.
authors.forename: Justin S
authors.initials: JS
authors.lastname: Golub
authors.affiliation: Department of Otolaryngology-Head and Neck Surgery, University of Cincinnati College of Medicine, and Neurosensory Disorders Center at the University of Cincinnati Neuroscience Institute, Cincinnati, OH, USA.
authors.forename: Myles L
authors.initials: ML
authors.lastname: Pensak
authors.affiliation: Department of Otolaryngology-Head and Neck Surgery, University of Cincinnati College of Medicine, and Neurosensory Disorders Center at the University of Cincinnati Neuroscience Institute, Cincinnati, OH, USA Ravi.Samy@UC.edu.
authors.forename: Ravi N
authors.initials: RN
authors.lastname: Samy
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D005158:Facial Paralysis / Q000139:chemically induced* / Q000175:diagnosis; D006801:Humans; D007262:Infusions, Intravenous; D000074324:Ipilimumab; D008297:Male; D008545:Melanoma / Q000175:diagnosis / Q000188:drug therapy* / Q000556:secondary; D010307:Parotid Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000556:secondary; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D000074324:Ipilimumab
keywords: facial palsy; ipilimumab; neuropathy